Acyclovir Capsule
Product Images NDC 61442-114

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 61442-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carlsbad Technology, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Principal Display Panel (6144211401)

Acyclovir Capsules USP 200 mg oral medication packaging label by Carlsbad Technology, Inc. The label shows the NDC number 61442-114-01, specifies 100 capsules per package, and includes storage instructions to keep at 20° to 25°C (68° to 77°F). It also features a barcode and manufacturing details. The label emphasizes dispensing in a tight container and provides a revision date of 02/17.*

FDA Label Image

Package Label – Principal Display Panel (6144211405)

Label for Acyclovir Capsules USP, 200 mg, containing 500 capsules. The label shows the proprietary name Acyclovir with the strength 200 mg prominently displayed, manufactured and distributed by Carlsbad Tech, Carlsbad, CA. It includes dosage, storage instructions, and a barcode with corresponding NDC 61442-114-05.*

FDA Label Image

Structural Formula (Acy03 0000 01)

Chemical structure of Acyclovir, showing its molecular arrangement and atomic connections as depicted in the image.*

FDA Label Image

Table 1 (Acy03 0000 02)

A data table titled 'Acyclovir Pharmacokinetic Characteristics (Range)' listing three pharmacokinetic parameters: plasma protein binding (9% to 33%), plasma elimination half-life (2.5 to 3.3 hours), and average oral bioavailability (10% to 20%) with a note that bioavailability decreases with increasing dose.*

FDA Label Image

Table 2 (Acy03 0000 03)

A data table titled 'Table 2. Acyclovir Peak and Trough Concentrations at Steady State' presenting pharmacokinetic parameters including peak (C SS max) and trough (C SS trough) plasma concentrations at steady state for 200 mg, 400 mg, and 800 mg doses of Acyclovir in mcg/mL.*

FDA Label Image

Table 3 (Acy03 0000 04)

A data table titled 'Dosage Modification for Renal Impairment' showing adjusted dosage regimens of Acyclovir capsules based on normal dosage regimens and patient creatinine clearance levels (mL/min/1.73 m2). It lists dose amounts in mg and corresponding dosing intervals for various levels of kidney function.*

FDA Label Image

Imprint Cti 114 (Acy03 0000 05)

Acyclovir 200 mg oral capsules packaging label from Carlsbad Technology, Inc. The label shows the product name 'Acyclovir' prominently along with the capsule dosage form and strength of 200 mg. The product is presented as a human prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.